Literature DB >> 27871505

Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial.

Laurie Putz1, Christophe Dransart2, Jacques Jamart3, Maria-Laura Marotta4, Geraldine Delnooz2, Philippe E Dubois2.   

Abstract

OBJECTIVE: To determine if reversing a deep or moderate block with sugammadex, compared with a shallow block reversed with neostigmine, reduces the time to operating room discharge after surgery and the time spent in the postanesthesia care unit.
DESIGN: A randomized controlled trial.
SETTING: Monocentric study performed from February 2011 until May 2012. PATIENTS: One hundred consenting women with American Society of Anesthesiologists grade I or II were randomized into 2 groups. INTERVENTION: Laparoscopic hysterectomy was performed under desflurane general anesthesia. For the neostigmine (N) group, 0.45 mg · kg-1 rocuronium was followed by spontaneous recovery. A 5-mg rescue bolus was administered only if surgical evaluation was unacceptable. At the end of surgery, 50 μg · kg-1 neostigmine with glycopyrrolate was administered. For the sugammadex (S) group, a higher intubating rocuronium dose (0.6 mg · kg-1) was followed by 5-mg boluses each time the train-of-four count exceeded 2. Sugammadex (2-4 mg · kg-1) was administered to reverse the block. All patients were extubated after obtaining a train-of-four ratio of 0.9. MEASUREMENTS: The duration between the end of surgery and operating room discharge and the time spent in the postanesthesia care unit. MAIN
RESULTS: The time till operating room discharge was shorter and more predictable in group S (9.15±4.28 minutes vs 13.87±11.43 minutes in group N; P=.005). The maximal duration in group S was 22 minutes, compared with 72 minutes in group N. The time spent in the postanesthesia care unit was not significantly different (group S: 47.75±31.77 minutes and group N: 53.43±40.57 minutes; P=.543).
CONCLUSION: Maintaining a deep neuromuscular block during laparoscopic hysterectomy reversed at the end of the procedure with sugammadex enabled a faster and more predictable time till operating room discharge than did the classical combination of a shallower block reversed with neostigmine.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Neostigmine; Neuromuscular blockade; Recovery room; Rocuronium; Sugammadex

Mesh:

Substances:

Year:  2016        PMID: 27871505     DOI: 10.1016/j.jclinane.2016.07.030

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  3 in total

1.  Sugammadex in awakening from general anesthesia: systematic review and meta-analysis.

Authors:  Adriano Anzai; Armelin Utino; Giuliano Tosello; Haroldo Katayama; Ighor Alexander Zamuner Spir; Luca Schiliró Tristão; Mary Martins Nery; Mauricio Anhesini; Osvaldo Silvestrini Tiezzi; Patricia Rodrigues Naufal Spir; Pericles Otani; Wanderley Marques Bernado
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

2.  Reduction of Nonoperative Time Using the Induction Room, Parallel Processing, and Sugammadex: A Randomized Clinical Trial.

Authors:  Roland Kaddoum; Said Tarraf; Fadia M Shebbo; Arwa Bou Ali; Cynthia Karam; Carol Abi Shadid; Joanna Bouez; Marie T Aouad
Journal:  Anesth Analg       Date:  2022-06-03       Impact factor: 6.627

Review 3.  Sugammadex, the Guardian of Deep Muscle Relaxation During Conventional and Robot-Assisted Laparoscopic Surgery: A Narrative Review.

Authors:  Yan Sun; Zhilin Wu; Qi Wang; Rui Chen; Shujun Sun; Yun Lin
Journal:  Drug Des Devel Ther       Date:  2021-09-14       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.